A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.

The Journal of Cell Biology
C WhitehouseJ Taylor-Papadimitriou

Abstract

The alpha2,3 sialyltransferase, alpha2,3 SAT (O), catalyzes the transfer of sialic acid to Galbeta1,3 N-acetyl-D-galactosamine (GalNAc) (core-1) in mucin type O-glycosylation, and thus terminates chain extension. A Core-2 branch can also be formed from core-1 by the core-2 beta1,6 N-acetyl-d-glucosamine transferase (beta1,6 GlcNAc T) that leads to chain extension. Increased levels of the alpha2,3 SAT (O) and decreased levels of the core-2 beta1,6 GlcNAc T are seen in breast cancer cells and correlate with differences in the structure of the O-glycans synthesized (Brockhausen et al., 1995; Lloyd et al., 1996). Since in mucin type O-glycosylation sugars are added individually and sequentially in the Golgi apparatus, the position of the transferases, as well as their activity, can determine the final structure of the O-glycans synthesized. A cDNA coding for the human alpha2,3 SAT (O) tagged with an immunoreactive epitope from the myc gene has been used to map the position of the glycosyltransferase in nontumorigenic (MTSV1-7) and malignant (T47D) breast epithelial cell lines. Transfectants were analyzed for expression of the enzyme at the level of message and protein, as well as for enzymic activity. In T47D cells, which do not ex...Continue Reading

References

May 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I KeydarH J Brenner
Jun 19, 1992·International Journal of Cancer. Journal International Du Cancer·M ShearerJ Taylor-Papadimitriou
May 29, 1992·Biochemical and Biophysical Research Communications·L PembertonS J Gendler
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J BartekJ Taylor-Papadimitriou
Dec 31, 1990·Biochemical and Biophysical Research Communications·C A LancasterS J Gendler
Dec 1, 1985·Molecular and Cellular Biology·G I EvanJ M Bishop
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Oct 15, 1995·European Journal of Biochemistry·I BrockhausenJ Taylor-Papadimitriou
Aug 12, 1993·Annals of the New York Academy of Sciences·J Magarian-BlanderO J Finn
Feb 1, 1994·The Journal of Cell Biology·P SlusarewiczG Warren
Aug 1, 1993·Current Opinion in Cell Biology·C E Machamer
Jul 1, 1996·Journal of Biochemistry·S Tsuji
Jul 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S von Mensdorff-PouillyJ Hilgers

❮ Previous
Next ❯

Citations

Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·K M McDermottM A Hollingsworth
Aug 11, 2000·Pathology Oncology Research : POR·M V CroceA Segal-Eiras
Dec 26, 2007·Glycoconjugate Journal·Manisha H ShahPrabhudas S Patel
Nov 6, 2002·Biochimica Et Biophysica Acta·Minoru Fukuda
Aug 6, 1999·Biochimica Et Biophysica Acta·T PetrettiW Kemmner
Dec 2, 1999·Biochimica Et Biophysica Acta·I Brockhausen
Mar 12, 2002·Glycobiology·Eric G Berger
Nov 24, 1999·Glycobiology·J BurchellJ Taylor-Papadimitriou
Apr 20, 2001·Biological Chemistry·F G Hanisch
Aug 26, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·C Ronin
Jul 20, 2010·Immunotherapy·Richard E BeatsonJoy M Burchell
Jun 8, 2001·Biochemical and Biophysical Research Communications·C Y WuY C Tsai
Mar 29, 2014·Trends in Molecular Medicine·Sritama Nath, Pinku Mukherjee
Jun 21, 2014·Biochimica Et Biophysica Acta·Fabio Dall'OlioMariella Chiricolo
Jul 5, 2005·Expert Opinion on Investigational Drugs·D W Miles, J Taylor-Papadimitriou
Dec 15, 2010·Trends in Cell Biology·David J GillFrederic Bard
Nov 9, 2007·Biochimica Et Biophysica Acta·Mads Agervig Tarp, Henrik Clausen
May 19, 2011·Annals of Medicine·Antti RivinojaSakari Kellokumpu
Sep 8, 2012·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·R R DreschM M Vozári-Hampe
Nov 26, 1999·Biochimica Et Biophysica Acta·J Taylor-PapadimitriouM Dalziel
Jun 17, 2010·Biophysical Journal·Jens KühnleMatthias Weiss
Nov 5, 2014·Frontiers in Immunology·Inka Brockhausen
Nov 29, 2001·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·F WangS Yonezawa
Jul 12, 2003·The Journal of Biological Chemistry·Christopher L de Graffenried, Carolyn R Bertozzi

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
transfect
transfection
FCS
protein assay
FACS
PCR
Light Microscopy

Software Mentioned

FACS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.